Central nervous system relapse after allogeneic HCT in FLT3-mutated AML
Khouloud Kouidri, Fabian Acker, Rosa Toenges, Saskia Pfaff, Sarah Lindner, Julia Riemann, Marek Werth, Salem Ajib, Fabian Lang, Björn Steffen, Thomas Oellerich, Hubert Serve, Anjali Cremer, Gesine Bug · 2024
Read Central nervous system relapse after allogeneic HCT in FLT3-mutated AML by Khouloud Kouidri, Fabian Acker, Rosa Toenges, Saskia Pfaff, Sarah Lindner, Julia Riemann, Marek Werth, Salem Ajib, Fabian Lang, Björn Steffen, Thomas Oellerich, Hubert Serve, Anjali Cremer, Gesine Bug (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11695448.txt.
Description
Khouloud Kouidri and thirteen co-authors study a rare but deadly turn in leukemia care: relapse inside the central nervous system after a stem cell transplant. The study covered 39 patients with a fast-growing leukemia marked by the FLT3 mutation, all treated at one center. Whether the disease had been beaten back before transplant proved decisive. Patients entering transplant in remission had no nervous system relapses in two years of follow-up.
Among patients whose disease was still active at transplant, half suffered a nervous system relapse within two years. Drugs aimed at the mutation, given before or after relapse, did not erase that risk. The authors suggest extra guardrails for the high-risk group, such as targeted therapy before transplant, preventive chemotherapy into the spinal fluid, or closer watching after the procedure.
Catalog record
| CREATOR | Khouloud Kouidri, Fabian Acker, Rosa Toenges, Saskia Pfaff, Sarah Lindner, Julia Riemann, Marek Werth, Salem Ajib, Fabian Lang, Björn Steffen, Thomas Oellerich, Hubert Serve, Anjali Cremer, Gesine Bug |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |